Recombinant Human Soluble Thrombomodulin and Short-Term Mortality of Sepsis Patients with Disseminated Intravascular Coagulation: a Meta-Analysis

被引：0
|
作者：
Zhang, C. [1 ]
Tong, Z. [1 ]
机构：
[1] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1815
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF COMBINATION THERAPY OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN AND ANTITHROMBIN ON DISSEMINATED INTRAVASCULAR COAGULATION WITH SEVERE SEPSIS
    Ikeda, K.
    INTENSIVE CARE MEDICINE, 2012, 38 : S295 - S295
  • [22] Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: A retrospective cohort study
    Kato T.
    Sakai T.
    Kato M.
    Hagihara M.
    Hasegawa T.
    Matsuura K.
    Nakagawa T.
    Thrombosis Journal, 11 (1)
  • [23] Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation
    Tagami, Takashi
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    FRONTIERS IN MEDICINE, 2015, 2
  • [24] RANDOMIZED CONTROLLED TRIAL OF NOVEL RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN (RTM) FOR SEPSIS WITH DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS IN JAPAN
    Ushizawa, H.
    Isotani, E.
    Takahashi, H.
    Sera, T.
    Otomo, Y.
    INTENSIVE CARE MEDICINE, 2012, 38 : S293 - S294
  • [25] EFFECTS OF RECOMBINANT HUMAN THROMBOMODULIN ON SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
    Uemura, Tatsuki
    Hiruma, Hiromitsu
    Hagiwara, Akiyoshi
    Makinouchi, Ryuichiro
    Matsuda, Wataru
    Kimura, Akio
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [26] Erratum to: Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation
    Akira Shirahata
    Jun Mimuro
    Hoyu Takahashi
    Isao Kitajima
    Hajime Tsuji
    Yutaka Eguchi
    Tadashi Matsushita
    Masahiro Kajiki
    Goichi Honda
    Yoichi Sakata
    European Journal of Pediatrics, 2014, 173 : 1405 - 1406
  • [27] Safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation (DIC)
    Kobayashi, T.
    Kajiki, M.
    Nihashi, K.
    Honda, G.
    THROMBOSIS RESEARCH, 2019, 175 : S1 - S2
  • [28] Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction
    Hayakawa, Mineji
    Kushimoto, Shigeki
    Watanabe, Eizo
    Goto, Koji
    Suzuki, Yasushi
    Kotani, Toru
    Kiguchi, Takeyuki
    Yatabe, Tomoaki
    Tagawa, Jun
    Komatsu, Fumiyo
    Gando, Satoshi
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (05) : 851 - 859
  • [29] Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation
    Kobayashi, Takao
    Kajiki, Masahiro
    Nihashi, Katsuhito
    Honda, Goichi
    THROMBOSIS RESEARCH, 2017, 159 : 109 - 115
  • [30] Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
    Jumpei Yoshimura
    Kazuma Yamakawa
    Hiroshi Ogura
    Yutaka Umemura
    Hiroki Takahashi
    Miki Morikawa
    Yoshiaki Inoue
    Satoshi Fujimi
    Hiroshi Tanaka
    Toshimitsu Hamasaki
    Takeshi Shimazu
    Critical Care, 19
12345